Resolutions adopted at the Annual General Meeting 2019
Today,
- The annual report for the financial year 2018/19 was adopted.
- Distribution of year-end dividend of
DKK 12.00 per share of nominallyDKK 1.00 was approved. In addition to the interim dividend ofDKK 5.00 per share of nominallyDKK 1.00 paid out in connection with Coloplast A/S’ half-year results, this brings the total dividend paid for the year toDKK 17.00 per share of nominallyDKK 1.00 .
- The remuneration report for the financial year 2018/19 was approved.
- The following proposals from the Board of Directors were adopted:
- The remuneration of the members of the Board of Directors for the financial year 2019/20.
- Updated remuneration policy complying with the new requirements under sections 139 and 139a of the Danish Companies Act.
- Amendment of Article 8 of Coloplast A/S’ Articles of Association – Agenda. Two new agenda items are included, (i) presentation and approval of the remuneration report, and (ii) approval of the Board of Directors’ remuneration for the current financial year.
- Amendment of Article 9 of Coloplast A/S’ Articles of Association – Forwarding of admission cards.
- Authorisation to the Board of Directors to acquire treasury shares until
4 December 2024 . The Board of Directors is authorised to allowColoplast A/S to acquire treasury shares for up to 10% of Coloplast A/S’ share capital, provided the total holding of treasury shares does not exceed 10% of Coloplast A/S’ share capital at any time. The highest and lowest amount to be paid for such shares is the price applicable at the time of acquisition of Coloplast A/S B shares +/- 10%.
- The remuneration of the members of the Board of Directors for the financial year 2019/20.
- Lars Søren Rasmussen,
Niels Peter Louis-Hansen ,Birgitte Nielsen ,Carsten Hellmann ,Jette Nygaard-Andersen and Jørgen Tang-Jensen were re-elected to the Board of Directors.
- PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab was re-elected.
Immediately after the Annual General Meeting, the Board of Directors elected Lars Søren Rasmussen as Chairman and
For more information, please contact:
Investors and analysts
Executive Vice President, CFO
Tel. +45 4911 1111
Ellen Bjurgert
Vice President
Investor Relations
Tel. +45 4911 1800 / 4911 3376
E-mail dkebj@coloplast.com
Senior Manager
Investor Relations
Tel. +45 4911 1800 / 4911 1786
E-mail dkraso@coloplast.com
Press and the media
Lina Danstrup
Senior Media Relations Manager
Corporate Communications
Tel. +45 4911 2607
E-mail dklina@coloplast.com
Address
Holtedam 1
DK-3050 Humlebaek
Business reg. (CVR) no. 69749917
Website
www.coloplast.com
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.
The
All rights reserved
Attachment
- 13_2019_Decisions_of_AGM
© OMX, source